Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9.
about
Inhibition of epithelial-mesenchymal transition in bladder cancer cells via modulation of mTOR signalling.Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway?Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches.
P2860
Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Myrtucommulone-A treatment dec ...... ladder cancer cell line HTB-9.
@en
type
label
Myrtucommulone-A treatment dec ...... ladder cancer cell line HTB-9.
@en
prefLabel
Myrtucommulone-A treatment dec ...... ladder cancer cell line HTB-9.
@en
P2093
P2860
P1476
Myrtucommulone-A treatment dec ...... ladder cancer cell line HTB-9.
@en
P2093
Banu Iskender
Halit Canatan
Halit Karaca
Kenan Izgi
P2860
P2888
P304
P356
10.1007/S11418-015-0923-7
P577
2015-06-09T00:00:00Z
P6179
1026495015